Literature DB >> 10445280

Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas.

S Vidal1, L Syro, E Horvath, H Uribe, K Kovacs.   

Abstract

Monomorphous pituitary adenomas expressing several hormones by immunocytochemistry are common, whereas adenomas displaying multiple immunoreactivities and consisting of more than one morphologic cell types are rare. Three such unusual pituitary adenomas, surgically removed from two patients with acromegaly and one patient with hyperprolactinemia, were investigated by histology, immunocytochemistry, transmission electron microscopy, as well as immunoelectron microscopy using double immunogold labeling. Immunocytochemistry revealed variable degrees of immunoreactivities for growth hormone (GH), prolactin (PRL), thyroid-stimulating hormone (beta-TSH), and alpha-subunit of glycoprotein hormones in all three tumors. The three adenomas consisted of phenotypically diverse cell populations as documented by transmission electron microscopy. In addition to monohormonal GH cells, immunoelectron microscopy demonstrated numerous cells colocalizing GH and PRL or GH and beta-TSH, and rarely PRL and beta-TSH in tumors of acromegalics. The adenoma causing hyperprolactinemia consisted chiefly of mammosomatotrophs colocalizing PRL and GH, whereas beta-TSH labeling was scant. The three tumors in the study were selected from a cluster of five plurimorphous plurihormonal adenomas received from the same locale where they accounted for an unprecedented 21% of adenomas producing GH and/or PRL. The enhanced susceptibility to develop plurimorphous adenomas of the acidophil cell line may have a genetic basis in the stable population the patients came from.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445280     DOI: 10.1080/019131299281635

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  8 in total

1.  Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.

Authors:  R A Jastania; K O Alsaad; M Al-Shraim; K Kovacs; S L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 2.  Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.

Authors:  Luis V Syro; Fabio Rotondo; Carlos A Serna; Leon D Ortiz; Kalman Kovacs
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.

Authors:  Odelia Cooper; Anat Ben-Shlomo; Vivien Bonert; Serguei Bannykh; James Mirocha; Shlomo Melmed
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

4.  Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity.

Authors:  Nicholas A Tritos; Samatha Eppakayala; Brooke Swearingen; E Tessa Hedley-Whyte; Karen K Miller; Lisa B Nachtigall; Steven K Grinspoon; Beverly M K Biller; Anne Klibanski
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

Review 5.  Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature.

Authors:  Elizabeth Ogando-Rivas; Andrew F Alalade; Jerome Boatey; Theodore H Schwartz
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

6.  Single-Cell Phenotypic Characterization of Human Pituitary GHomas and Non-Functioning Adenomas Based on Hormone Content and Calcium Responses to Hypothalamic Releasing Hormones.

Authors:  Laura Senovilla; Lucía Núñez; José María de Campos; Daniel A de Luis; Enrique Romero; Javier García-Sancho; Carlos Villalobos
Journal:  Front Oncol       Date:  2015-06-09       Impact factor: 6.244

7.  Plurihormonal cells of normal anterior pituitary: Facts and conclusions.

Authors:  Lubov B Mitrofanova; Petr V Konovalov; Julia S Krylova; Victoria O Polyakova; Igor M Kvetnoy
Journal:  Oncotarget       Date:  2017-04-25

8.  Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.

Authors:  David T Asuzu; Reinier Alvarez; Patrick A Fletcher; Debjani Mandal; Kory Johnson; Weiwei Wu; Abdel Elkahloun; Paul Clavijo; Clint Allen; Dragan Maric; Abhik Ray-Chaudhury; Sharika Rajan; Zied Abdullaev; Diana Nwokoye; Kenneth Aldape; Lynnette K Nieman; Constantine Stratakis; Stanko S Stojilkovic; Prashant Chittiboina
Journal:  Cell Rep       Date:  2022-08-23       Impact factor: 9.995

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.